---
title: "Peijia Medical Sees Up to 43% Jump in 2024 Revenue"
date: "2025-02-10 18:50:06"
summary: "Peijia Medical forecasts its 2024 revenue to surge by 38% to 43% year-over-year to between 610 million yuan and 630 million yuan. The surge is attributable to growth in the medical equipment company's neuro-interventional product lines and a greater share in the Chinese transcatheter aortic valve replacement market, according to..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Peijia Medical forecasts its 2024 revenue to surge by 38% to 43% year-over-year to between 610 million yuan and 630 million yuan.

The surge is attributable to growth in the medical equipment company's neuro-interventional product lines and a greater share in the Chinese transcatheter aortic valve replacement market, according to a Monday filing with the Hong Kong Exchange.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465717:0/)
